OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 12, pp. 3080-3089
Open Access | Times Cited: 13
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 12, pp. 3080-3089
Open Access | Times Cited: 13
Showing 13 citing articles:
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Jenneke Leentjens, Thijs F. van Haaps, Pieter Wessels, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 7, pp. e524-e533
Open Access | Times Cited: 219
Jenneke Leentjens, Thijs F. van Haaps, Pieter Wessels, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 7, pp. e524-e533
Open Access | Times Cited: 219
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
Hideo Wada, Katsuya Shiraki, Hideto Shimpo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7975-7975
Open Access | Times Cited: 15
Hideo Wada, Katsuya Shiraki, Hideto Shimpo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7975-7975
Open Access | Times Cited: 15
SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity
Kevin H. Toomer, Gloria F. Gerber, Yifan Zhang, et al.
eJHaem (2023) Vol. 4, Iss. 2, pp. 324-338
Open Access | Times Cited: 12
Kevin H. Toomer, Gloria F. Gerber, Yifan Zhang, et al.
eJHaem (2023) Vol. 4, Iss. 2, pp. 324-338
Open Access | Times Cited: 12
Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm
Shinya Yamada, Hidesaku Asakura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1296-1296
Open Access | Times Cited: 20
Shinya Yamada, Hidesaku Asakura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1296-1296
Open Access | Times Cited: 20
Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
Shinya Yamada, Hidesaku Asakura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3338-3338
Open Access | Times Cited: 20
Shinya Yamada, Hidesaku Asakura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3338-3338
Open Access | Times Cited: 20
Association between antithrombotic therapy and mortality in patients hospitalized for COVID‑19
Xing Wang, Wuqian Chen, Jiulin Guo, et al.
Thrombosis Journal (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Xing Wang, Wuqian Chen, Jiulin Guo, et al.
Thrombosis Journal (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Protecting older patients with cardiovascular diseases from COVID-19 complications using current medications
Mariana Alves, Marília Andreia Fernandes, Gülistan Bahat, et al.
European Geriatric Medicine (2021) Vol. 12, Iss. 4, pp. 725-739
Open Access | Times Cited: 9
Mariana Alves, Marília Andreia Fernandes, Gülistan Bahat, et al.
European Geriatric Medicine (2021) Vol. 12, Iss. 4, pp. 725-739
Open Access | Times Cited: 9
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Closer to FREEDOM From Uncertainty
Muthiah Vaduganathan, Behnood Bikdeli
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1763-1765
Open Access | Times Cited: 1
Muthiah Vaduganathan, Behnood Bikdeli
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 18, pp. 1763-1765
Open Access | Times Cited: 1
Screening of Potential Indonesia Herbal Compounds Based on Multi-Label Classification for 2019 Coronavirus Disease
Aulia Fadli, Wisnu Ananta Kusuma, Annisa Annisa, et al.
Big Data and Cognitive Computing (2021) Vol. 5, Iss. 4, pp. 75-75
Open Access | Times Cited: 3
Aulia Fadli, Wisnu Ananta Kusuma, Annisa Annisa, et al.
Big Data and Cognitive Computing (2021) Vol. 5, Iss. 4, pp. 75-75
Open Access | Times Cited: 3
To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
Behnood Bikdeli
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 4, pp. e12738-e12738
Open Access | Times Cited: 2
Behnood Bikdeli
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 4, pp. e12738-e12738
Open Access | Times Cited: 2
P-Selectin de-ACTIVation in COVID-19: What Have We Learned?
Behnood Bikdeli, John W. Eikelboom
Circulation (2023) Vol. 148, Iss. 5, pp. 391-393
Open Access
Behnood Bikdeli, John W. Eikelboom
Circulation (2023) Vol. 148, Iss. 5, pp. 391-393
Open Access
